Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
Sold rose from $696.9M to $727.1M (+$30.2M) in 364 days since the previous filing.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2025-04-03 | D/A | $696.9M | 2 | |
| 2026-04-02 | D/A | $727.1M | 2 | +$30.2M |
| 2026-05-12 | D/A | $727.1M | 2 | $0 |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Earlier and related filings by the same issuer and sponsor. All Paradigm Biocapital International vehicles →
PARADIGM BIOCAPITAL ADVISORS LP
Website and main-office phone from Form ADV. Subscribe to unlock
Schedule D for this adviser has not been read yet; it is queued.
9 other filings on EDGAR under this adviser, with size, strategy and date. Subscribe to unlock
| N/A Paradigm BioCapital Advisors LP | Promoter |
| Senai Asefaw | Executive Officer, Director |
| Victor Murray | Director |
| Alaina Danley | Director |
Signed by Senai Asefaw, Director.
Relevant to: Fund audit & tax, Fund administrator, Placement agent / capital introduction, Custodian / prime broker.
The issuer's phone number and address from the filing are shown to subscribers. See plans.
